TDP2 Antikörper (C-Term) (FITC)
-
- Target Alle TDP2 Antikörper anzeigen
- TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))
-
Bindungsspezifität
- AA 253-281, C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TDP2 Antikörper ist konjugiert mit FITC
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF), Flow Cytometry (FACS)
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- EAPII, CT (TDP2, EAP2, TTRAP, Tyrosyl-DNA phosphodiesterase 2, 5'-tyrosyl-DNA phosphodiesterase, ETS1-associated protein 2, ETS1-associated protein II, TRAF and TNF receptor-associated protein) (FITC)
- Aufreinigung
- Purified by Protein A affinity chromatography.
- Immunogen
- EAPII antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 253-281 amino acids from the C-terminal region of human EAPII.
- Isotyp
- IgG
- Top Product
- Discover our top product TDP2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))
- Andere Bezeichnung
- EAPII (TDP2 Produkte)
- NCBI Accession
- NP_057698
- UniProt
- O95551
-